275 related articles for article (PubMed ID: 30639794)
21. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - Expertise France).
Coulaud PJ; Sagaon-Teyssier L; M'madi Mrenda B; Maradan G; Mora M; Bourrelly M; Dembélé Keita B; Keita AA; Anoma C; Babo Yoro SA; Dah TTE; Coulibaly C; Mensah E; Agbomadji S; Bernier A; Couderc C; Laurent C; Spire B;
Trop Med Int Health; 2018 Oct; 23(10):1084-1091. PubMed ID: 30055043
[TBL] [Abstract][Full Text] [Related]
22. An Exploration of Factors Impacting Preexposure Prophylaxis Eligibility and Access Among Syringe Exchange Users.
Roth AM; Aumaier BL; Felsher MA; Welles SL; Martinez-Donate AP; Chavis M; Van Der Pol B
Sex Transm Dis; 2018 Apr; 45(4):217-221. PubMed ID: 29465703
[TBL] [Abstract][Full Text] [Related]
23. Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study.
Jacka BP; Nolen S; Bessey SE; Zang X; Goedel WC; Yedinak JL; Marshall BDL
J Acquir Immune Defic Syndr; 2022 Dec; 91(5):449-452. PubMed ID: 36150038
[TBL] [Abstract][Full Text] [Related]
24. "Take services to the people": strategies to optimize uptake of PrEP and harm reduction services among people who inject drugs in Uganda.
Kamusiime B; Beima-Sofie K; Chhun N; Nalumansi A; Nalukwago GK; Kasiita V; Twesige CC; Kansiime R; Muwonge TR; Kyambadde P; Kadama H; Mudiope P; Glick S; Lambdin B; Mujugira A; Heffron R
Addict Sci Clin Pract; 2024 Feb; 19(1):13. PubMed ID: 38395940
[TBL] [Abstract][Full Text] [Related]
25. HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.
Walters SM; Kral AH; Simpson KA; Wenger L; Bluthenthal RN
Subst Use Misuse; 2020; 55(14):2409-2419. PubMed ID: 32962490
[TBL] [Abstract][Full Text] [Related]
26. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
[TBL] [Abstract][Full Text] [Related]
27. Perceptions of people who inject drugs towards HIV pre-exposure prophylaxis in Australia.
Read P; Chronister KJ; Kostovski C; Harrod ME; Salmon A; Jauncey M
Sex Health; 2019 Aug; 16(4):383-388. PubMed ID: 31203837
[TBL] [Abstract][Full Text] [Related]
28. Awareness and Interest in HIV Pre-Exposure Prophylaxis Among Street-Based Female Sex Workers: Results from a US Context.
Tomko C; Park JN; Allen ST; Glick J; Galai N; Decker MR; Footer KHA; Sherman SG
AIDS Patient Care STDS; 2019 Feb; 33(2):49-57. PubMed ID: 30632769
[TBL] [Abstract][Full Text] [Related]
29. Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings.
King AR; Shah S; Randall LA; Frew PM; Spaulding A; ; Holloway IW
BMC Infect Dis; 2022 Sep; 22(1):737. PubMed ID: 36104676
[TBL] [Abstract][Full Text] [Related]
30. Qualitative inquiry into perceptions of HIV pre-exposure prophylaxis among people who inject drugs living with hepatitis C in Seattle, WA, USA.
Barry MP; Austin EJ; Bhatraju EP; Glick SN; Stekler JD; Tung EL; Hansen RN; Williams EC; Gojic AJ; Pickering EI; Tsui JI
Harm Reduct J; 2022 Nov; 19(1):121. PubMed ID: 36320005
[TBL] [Abstract][Full Text] [Related]
31. The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.
Mistler CB; Copenhaver MM; Shrestha R
AIDS Behav; 2021 May; 25(5):1490-1506. PubMed ID: 32749627
[TBL] [Abstract][Full Text] [Related]
32. Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
McKellar MS; Des Marais AC; Chen H; Choi Y; Lilly R; Ayers D; Bennett J; Kestner L; Perry B; Poley S; Corneli A; Meade CS; Sachdeva N
Harm Reduct J; 2024 Mar; 21(1):69. PubMed ID: 38532395
[TBL] [Abstract][Full Text] [Related]
33. Structural vulnerabilities and PrEP awareness among Boston heterosexuals and people who inject drugs at risk for HIV: findings from 2018 to 2019 cycles from the Boston, MA site of the NHBS.
Lee JS; Batchelder AW; Stanton AM; Westphal L; Klevens RM; Mayer KH; O'Cleirigh C;
AIDS Care; 2024 May; 36(5):641-651. PubMed ID: 38091449
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus pre-exposure prophylaxis awareness among people who inject drugs in Portland, Oregon.
Spencer HC; Babiarz J; Menza TW
Int J STD AIDS; 2023 Jul; 34(8):567-573. PubMed ID: 36949570
[TBL] [Abstract][Full Text] [Related]
35. Perspectives on pre-exposure prophylaxis for people who inject drugs in the context of an hiv outbreak: A qualitative study.
Smith M; Elliott L; Hutchinson SJ; Metcalfe R; Flowers P; McAuley A
Int J Drug Policy; 2021 Feb; 88():103033. PubMed ID: 33249313
[TBL] [Abstract][Full Text] [Related]
36. Differences in awareness of and willingness to use pre-exposure prophylaxis and anticipated condom use among serodiscordant couples in Taiwan.
Ko NY; Wu HJ; Strong C; Li CW; Ku WW; Hsu ST
AIDS Care; 2018 Oct; 30(10):1306-1310. PubMed ID: 29845871
[TBL] [Abstract][Full Text] [Related]
37. Barriers and Facilitators to PrEP Use Among People Who Inject Drugs in Rural Appalachia: A Qualitative Study.
Allen ST; O'Rourke A; White RH; Smith KC; Weir B; Lucas GM; Sherman SG; Grieb SM
AIDS Behav; 2020 Jun; 24(6):1942-1950. PubMed ID: 31853771
[TBL] [Abstract][Full Text] [Related]
38. Applying the Behavioral Model for Vulnerable Populations to Pre-Exposure Prophylaxis Initiation Among Women Who Inject Drugs.
Felsher M; Bellamy S; Piecara B; Van Der Pol B; Laurano R; Roth AM
AIDS Educ Prev; 2020 Dec; 32(6):486-492. PubMed ID: 33779207
[TBL] [Abstract][Full Text] [Related]
39. Provider Implicit Bias in Prescribing HIV Pre-exposure Prophylaxis (PrEP) to People Who Inject Drugs.
Dubov A; Krakower DS; Rockwood N; Montgomery S; Shoptaw S
J Gen Intern Med; 2023 Oct; 38(13):2928-2935. PubMed ID: 36964426
[TBL] [Abstract][Full Text] [Related]
40. A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation.
Rosen JG; Zhang L; Pelaez D; Park JN; Glick JL
AIDS Behav; 2023 Jul; 27(7):2440-2453. PubMed ID: 36596866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
